FDA Inspection
MedisourceRxMedisourceRx – FDA Inspection, Oct 22, 2020
Record Details
This FDA Inspection record concerns MedisourceRx, with an inspection on October 22, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- MedisourceRx
- Inspection Date
- October 22, 2020
- Product Type
- Drugs
View Company Profile
ID · a41be081-b03d-43cf-bdf8-7b6507777311
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1131719
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.84(d)(2)Establish reliability of supplier"s C of A
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.186(b)(9)Manufacturing Instructions and Specifications
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of MedisourceRx
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2025 | OAI | Los Angeles District Office | Drug Quality Assurance |
| November 4, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2018 | Not classified | Los Angeles District Office | Drug Quality Assurance |
Other documents for MedisourceRx
- FDA Inspection 1272492 - 2025-06-10
- FDA Inspection 1191700 - 2022-11-04
- FDA Inspection 1067011 - 2018-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.